SCHEMBL7461579

SCHEMBL7461579

Cc1cc2c(cc1-c1ccc(/C=C3\SC(=O)NC3=O)cc1C(F)(F)F)C(C)(C)CCC2(C)C

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.49
ESRRA P11474 8/20 0.48
PIM1 P11309 7/20 0.48
PIM2 Q9P1W9 7/20 0.48
TTR P02766 1/20 0.48
CISD1 Q9NZ45 1/20 0.48
HPGD P15428 3/20 0.46
CYP3A4 P08684 1/20 0.46
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
ESRRB O95718 1/20 0.43
ESR1 P03372 1/20 0.43
ESRRG P62508 1/20 0.43
ESR2 Q92731 1/20 0.43
PARP1 P09874 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7461586 1.00 RXRA (0.49) RXRAESRRAPIM1PIM2TTR
SCHEMBL7461441 0.92 ESRRA (0.51) RXRAESRRAPIM1PIM2TTR
SCHEMBL7461440 0.92 ESRRA (0.51) RXRAESRRAPIM1PIM2TTR
SCHEMBL14492759 0.92 RXRA (0.51) RXRAESRRAPIM1PIM2TTR
SCHEMBL5490211 0.92 RXRA (0.51) RXRAESRRAPIM1PIM2TTR
SCHEMBL5490208 0.92 RXRA (0.51) RXRAESRRAPIM1PIM2TTR
SCHEMBL14492771 0.90 ESRRA (0.48) RXRAESRRAPIM1PIM2TTR
SCHEMBL5491435 0.90 ESRRA (0.48) RXRAESRRAPIM1PIM2TTR
SCHEMBL5491428 0.90 ESRRA (0.48) RXRAESRRAPIM1PIM2TTR
SCHEMBL7458010 0.88 PIM1 (0.52) RXRAPIM1PIM2CISD1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP claimed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO claimed
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP disclosed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO disclosed